Morphic Holding Inc (MORF)
29.27
-0.22
(-0.75%)
USD |
NASDAQ |
May 22, 16:00
29.27
0.00 (0.00%)
After-Hours: 20:00
Morphic Price to Book Value: 2.210 for May 22, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 21, 2024 | 2.226 |
| May 20, 2024 | 2.296 |
| May 17, 2024 | 2.207 |
| May 16, 2024 | 2.450 |
| May 15, 2024 | 2.282 |
| May 14, 2024 | 2.141 |
| May 13, 2024 | 2.165 |
| May 10, 2024 | 2.160 |
| May 09, 2024 | 2.199 |
| May 08, 2024 | 2.214 |
| May 07, 2024 | 2.274 |
| May 06, 2024 | 2.291 |
| May 03, 2024 | 2.257 |
| May 02, 2024 | 2.167 |
| May 01, 2024 | 2.112 |
| April 30, 2024 | 2.059 |
| April 29, 2024 | 2.112 |
| April 26, 2024 | 2.119 |
| April 25, 2024 | 2.112 |
| April 24, 2024 | 2.090 |
| April 23, 2024 | 2.170 |
| April 22, 2024 | 2.152 |
| April 19, 2024 | 2.113 |
| April 18, 2024 | 2.077 |
| April 17, 2024 | 2.104 |
| Date | Value |
|---|---|
| April 16, 2024 | 2.102 |
| April 15, 2024 | 2.228 |
| April 12, 2024 | 2.164 |
| April 11, 2024 | 2.289 |
| April 10, 2024 | 2.265 |
| April 09, 2024 | 2.323 |
| April 08, 2024 | 2.272 |
| April 05, 2024 | 2.275 |
| April 04, 2024 | 2.273 |
| April 03, 2024 | 2.394 |
| April 02, 2024 | 2.408 |
| April 01, 2024 | 2.484 |
| March 28, 2024 | 2.527 |
| March 27, 2024 | 2.469 |
| March 26, 2024 | 2.353 |
| March 25, 2024 | 2.308 |
| March 22, 2024 | 2.386 |
| March 21, 2024 | 2.487 |
| March 20, 2024 | 2.485 |
| March 19, 2024 | 2.434 |
| March 18, 2024 | 2.402 |
| March 15, 2024 | 2.480 |
| March 14, 2024 | 2.480 |
| March 13, 2024 | 2.484 |
| March 12, 2024 | 2.548 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.372
Minimum
Oct 31 2023
18.96
Maximum
Mar 01 2021
4.565
Average
4.075
Median
Price to Book Value Benchmarks
| Keros Therapeutics Inc | 4.052 |
| NovaBay Pharmaceuticals Inc | -- |
| Palatin Technologies Inc | 20.85 |
| iBio Inc | 0.7735 |
| Theriva Biologics Inc | 0.2081 |
Price to Book Value Related Metrics
| PS Ratio | 19.69 |
| Price | 29.27 |
| Earnings Yield | -11.96% |
| Market Cap | 1.466B |